SOP Guide for Pharma

BA-BE Studies: SOP for Use of LC-MS/MS in BA/BE Studies – V 2.0

Auditor

BA-BE Studies: SOP for Use of LC-MS/MS in BA/BE Studies – V 2.0

Standard Operating Procedure for Use of LC-MS/MS in Bioavailability and Bioequivalence Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/160/2025
Supersedes SOP/BA-BE/160/2022
Page No. Page 1 of 12
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To define the standard procedure for using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) for the quantification of drug compounds and metabolites in biological matrices during BA/BE studies.

2. Scope

This SOP is applicable to all bioanalytical scientists, analysts, and instrument operators involved in LC-MS/MS-based analysis of plasma and biological samples for pharmacokinetic evaluations in BA/BE studies.

3. Responsibilities

  • Analyst: Operates the LC-MS/MS as per validated method, performs basic maintenance, and documents data.
  • QA Personnel: Reviews data acquisition and chromatographic quality; investigates any deviations.
  • Lab Manager: Ensures system readiness, calibration, and compliance with regulatory guidelines.

4. Accountability

The Head of Bioanalytical Laboratory is accountable for ensuring proper use, qualification, and maintenance of LC-MS/MS instrumentation in compliance with ICH, FDA, EMA, and GLP requirements.

See also  BA-BE Studies: SOP for Sample Storage at -20°C and -70°C - V 2.0

5. Procedure

5.1 Pre-Operational Checks

  1. Ensure the LC-MS/MS system is calibrated and previously qualified (IQ/OQ/PQ completed).
  2. Check autosampler tray cleanliness, solvent levels, and waste container status.
  3. Review environmental conditions (temperature/humidity within acceptable range).

5.2 Mobile Phase and Column Preparation

  1. Prepare mobile phases as per validated method (e.g., water + 0.1% formic acid and acetonitrile).
  2. Degas mobile phases using ultrasonic bath or inline degasser.
  3. Install validated LC column and equilibrate for at least 30 minutes at specified flow rate.

5.3 Tuning and Calibration of MS

  1. Perform system tuning using the specified tuning solution (e.g., polytyrosine or PPG).
  2. Adjust source parameters (e.g., curtain gas, collision energy) for optimized ion transmission.
  3. Document instrument tuning in Annexure-1: Tuning Log.

5.4 Sample Injection and Sequence Setup

  1. Create an injection sequence that includes:
    • Blank samples
    • Calibration standards (low to high)
    • Quality control (QC) samples
    • Study samples
    • Reinjected QC and blanks for carryover
  2. Input batch details and file names in the data acquisition software.
  3. Run the sequence ensuring the MS/MS transitions are correctly monitored (MRM mode).

5.5 Data Acquisition

  1. Monitor signal intensity, retention time, and baseline noise throughout the run.
  2. Ensure injection reproducibility and peak integrity for QC samples.
  3. Any instrument interruption must be documented in the Instrument Interruption Log (Annexure-2).
See also  BA-BE Studies: SOP for Bioanalytical Sample Batch Preparation - V 2.0

5.6 System Suitability and Acceptance Criteria

  1. Verify that retention time, signal-to-noise ratio, and peak area of calibrators fall within acceptance criteria.
  2. Evaluate carryover by injecting blanks post high-concentration standards.
  3. Reject runs with failed calibration curve or QC deviation > ±15% (±20% at LLOQ).

5.7 Post-Run Activities

  1. Rinse LC lines with mobile phase and then water to prevent salt or buffer deposits.
  2. Shutdown system if not in use: stop flow, vent MS source, turn off ion source gases.
  3. Save raw data, transfer to secured server, and archive sequence files.

5.8 Troubleshooting

  1. Common issues:
    • No signal – Check spray voltage, capillary clog, or sample prep error
    • Drift in retention time – Verify pump pressure and mobile phase integrity
    • High background – Clean ion source or replace cone/skimmer

5.9 Documentation and Review

  1. Maintain batch run details in Annexure-3: LC-MS/MS Run Summary Sheet.
  2. Review integration and audit trail per GxP requirements.

6. Abbreviations

  • BA/BE: Bioavailability/Bioequivalence
  • LC-MS/MS: Liquid Chromatography – Tandem Mass Spectrometry
  • IQ/OQ/PQ: Installation/Operational/Performance Qualification
  • MRM: Multiple Reaction Monitoring
  • QC: Quality Control
See also  BA-BE Studies: SOP for Emergency Medical Resuscitation Kit Use - V 2.0

7. Documents

  1. Tuning Log – Annexure-1
  2. Instrument Interruption Log – Annexure-2
  3. LC-MS/MS Run Summary Sheet – Annexure-3

8. References

  • ICH M10: Bioanalytical Method Validation
  • FDA/EMA LC-MS/MS Regulatory Guidelines
  • Instrument Vendor Manuals (e.g., Sciex, Agilent, Waters)

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Tuning Log

Date Instrument ID Tuning Solution Operator Comments
17/04/2025 LCMS-01 PPG Rajesh Kumar Successful

Annexure-2: Instrument Interruption Log

Date Batch ID Nature of Issue Corrective Action Reviewer
17/04/2025 BE-101 No spray Cleaned source Sunita Reddy

Annexure-3: LC-MS/MS Run Summary Sheet

Run Date Batch No. Analyst No. of Samples Deviation
17/04/2025 BE-101 Vinay Pawar 48 No

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
17/04/2025 2.0 Integrated MRM settings and run summary tracking GxP Audit Feedback QA Head
Exit mobile version